Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome

Clinical trial NCT00003959 · COMPLETED

Trial details

NCT number: NCT00003959
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndromes

Start date: 1999-06-01
Primary completion: 2001-12-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.